Skip to search.
 TSX Up 0.74% TSX Ventures Up 0.24%

Geron Corporation (GERN)

-NasdaqGS
2.08 Down 0.04(1.89%) 4:00PM EST
Prev Close:2.12
Open:2.10
Bid:2.02 x 200
Ask:2.23 x 700
1y Target Est:4.38
Beta:2.87363
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:2.02 - 2.12
52wk Range:1.81 - 5.15
Volume:1,350,168
Avg Vol (3m):1,897,870
Market Cap:331.02M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 1.89%331.02M
BMYDown 1.41%92.32B
GSKDown 0.37%89.48B
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):53.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.19
Quarterly EPS Est (Dec-16) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-2.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback